Harm reduction package for an open drug scene (MEQ)

(i) Definition. Harm reduction is a pragmatic public-health and clinical approach that reduces health and social harms of drug use without requiring cessation as a precondition of care. Principles include humanism, pragmatism, incrementalism, autonomy, and accountability without termination — continued use is not automatic grounds for service expulsion. Abstinence may be a patient goal; abstinence-only gatekeeping (withholding sterile equipment, naloxone, or care until “clean”) is the opposite of evidence-aligned practice and raises death and BBV risk.[1]

(ii) Multi-component package. (1) Scale NSP with adequate syringe coverage, disposal, secondary distribution where legal, and BBV testing — meta-analytic association with reduced HIV transmission.[2] (2) Expand low-threshold OAT (methadone/buprenorphine) with retention focus; mortality is lower on treatment and rises after leaving (Sordo).[3] (3) Supervised consumption where legally feasible — Marshall showed ~35% reduction in fatal overdose within 500 m of Insite; Kerr showed reduced syringe sharing among facility users.[4] (4) Saturate take-home naloxone via ED, pharmacy, peers, prison release (McDonald & Strang Bradford Hill support).[5] (5) Outreach, housing pathways, and dual-diagnosis integration. Measure coverage and overdose deaths, not logos.

(iii) Individual plan. Same-day: non-stigmatising engagement; supply or facilitate sterile equipment; train patient and contacts on take-home naloxone (recognise hypoventilation, give IN/IM product dose, call emergency services, recovery position, repeat if needed); offer OAT re-induction with apology for prior punitive discharge — revise clinic policy so single benzo-positive UDS does not equal expulsion; assess benzo use for safety; HIV/HCV testing and wound care; housing and welfare. If he declines OAT today, keep the door open and maximise NSP/THN.[1][3][5]

(iv) “Wrong message” and stigma. Reframe: the message of combined harm reduction is that lives and blood-borne infections matter now, while treatment remains available. Supervised consumption and NSP do not equal endorsement of chaos; evaluated services reduce local overdose mortality and unsafe injecting indicators without the crime surge opponents predict as fact. Stigma — pejorative language, punitive discharge — itself contributes to the toll of addiction by blocking treatment uptake (Volkow).[4][6]

(v) High-risk transitions. Prison release; leaving detox or residential care without OAT; OAT interruption/missed doses with lost tolerance; post-non-fatal overdose discharge without MOUD/THN; solitary use and poly-sedative periods; fentanyl-contaminated supply spikes. Plan THN + OAT continuity at each transition.[3][5]